Percutaneous Vascular Interventions Versus Intravenous Thrombolytic Treatment for Acute Ischemic Stroke by Lindekleiv, Haakon et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percutaneous Vascular Interventions Versus Intravenous
Thrombolytic Treatment for Acute Ischemic Stroke
Citation for published version:
Lindekleiv, H, Bruins Slot, KMH, Wardlaw, JM & Berge, E 2019, 'Percutaneous Vascular Interventions
Versus Intravenous Thrombolytic Treatment for Acute Ischemic Stroke', Stroke.
https://doi.org/10.1161/STROKEAHA.118.024298
Digital Object Identifier (DOI):
10.1161/STROKEAHA.118.024298
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Stroke
Publisher Rights Statement:
This is the authors' peer-reviewed manuscript as accepted for publication.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Fo
r S
tro
ke
 Pe
er 
Re
vie
w. 
Do
 no
t d
ist
rib
ute
. D
es
tro
y
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aft
er 
us
e.
URL: http://stroke-submit.aha-journals.org 
Title: Percutaneous vascular interventions versus intravenous thrombolytic 
treatment for acute ischaemic stroke 
Manuscript number: STROKE/2018/024298 
Author(s): Haakon Lindekleiv 
Fo
r S
tro
ke
 Pe
er 
Re
vie
w. 
Do
 no
t d
ist
rib
ute
. D
es
tro
y
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aft
er 
us
e.
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Randomised trials have shown that percutaneous vascular interventions are superior 
to usual care in patients with stroke due to large artery occlusion. We have searched 
the literature for studies comparing percutaneous vascular interventions with 
intravenous thrombolytic treatment in patients with acute ischaemic stroke. 
Objectives 
The objective of our review1 was to assess the effectiveness and safety of 
percutaneous vascular interventions compared with intravenous thrombolytic 
treatment for acute ischaemic stroke. 
Search Methods 
We searched the Cochrane Stroke Group Trials Register (last search: August 2018). 
In addition, in September 2017, we searched the following electronic databases: 
CENTRAL, MEDLINE, EMBASE, Science Citation Index; Stroke Trials Registry, and 
ClinicalTrials.gov. 
Selection Criteria 
Randomised controlled trials  that directly compare a percutaneous vascular 
intervention with intravenous thrombolytic treatment in people with acute ischaemic 
stroke. 
Data Collection and Analysis 
Two review authors applied the inclusion criteria, extracted data, and assessed risk 
of bias. We obtained both published and unpublished data. We assessed the quality 
of the evidence using the GRADE approach. 
Main Results 
We included four trials with 450 participants2-5. Data on functional outcome and death 
at end of follow‐up were available for 443 participants from three trials.3-5 
Compared with intravenous thrombolytic therapy, percutaneous vascular intervention 
did not improve the proportion of participants with good functional outcome at end of 
follow-up (modified Rankin Scale score 0 to 2 at 3 months, risk ratio (RR) 1.01, 95% 
confidence interval (CI) 0.82 to 1.25, P=0.92; Figure). The quality of evidence was 
moderate (because outcome assessment was blinded, but not the treating physician 
or participants).  
There was also no reduction in the proportion of participants who died in the 
percutaneous vascular intervention group (RR 1.34, 95% CI 0.84 to 2.14, P=0.21), 
and no difference in the proportion of participants with symptomatic intracranial 
haemorrhage (RR 0.99, 95% CI 0.50 to 1.95, P=0.97). The quality of evidence was 
low (because confidence intervals were wide). 
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We found no evidence that percutaneous vascular interventions are superior to 
intravenous thrombolytic treatment in patients with acute ischaemic stroke. 
Sources of Funding 
South‐Eastern Norway Regional Health Authority, Norway. Educational grant. 
Disclosures 
KBS is currently employed by F. Hoffmann‐La Roche (Roche Norge AS). The data 
included in this review are based on research done before this employment and was 
not influenced by F. Hoffmann‐La Roche by any means. The views expressed in this 
review are the personal views of KBS and should not be understood or quoted as 
being made on behalf of or reflecting the position of F. Hoffmann‐La Roche. 
The other authors report no conflicts. 
Footnotes 
This paper is based on a Cochrane Review.1 Cochrane Reviews are regularly 
updated as new evidence emerges and in response to feedback. The Cochrane 
Library should be consulted for the most recent version of the review. 
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Figure legend 
Figure. Odds ratio of good outcome (modified Rankin Scale score 0‐2) in patients 
with acute ischaemic stroke treated with percutaneous vascular interventions versus 
intravenous thrombolytic treatment 
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